Beta Bionics (BBNX) Equity Ratio (2023 - 2025)
Beta Bionics (BBNX) has disclosed Equity Ratio for 3 consecutive years, with 0.87 as the latest value for Q4 2025.
- Quarterly Equity Ratio rose 153.36% to 0.87 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.87 through Dec 2025, up 153.36% year-over-year, with the annual reading at 0.87 for FY2025, 153.36% up from the prior year.
- Equity Ratio hit 0.87 in Q4 2025 for Beta Bionics, down from 0.89 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.93 in Q1 2025 to a low of 1.85 in Q4 2023.
- Historically, Equity Ratio has averaged 0.02 across 3 years, with a median of 0.88 in 2025.
- Biggest five-year swings in Equity Ratio: increased 11.17% in 2024 and later soared 153.36% in 2025.
- Year by year, Equity Ratio stood at 1.85 in 2023, then increased by 11.17% to 1.64 in 2024, then skyrocketed by 153.36% to 0.87 in 2025.
- Business Quant data shows Equity Ratio for BBNX at 0.87 in Q4 2025, 0.89 in Q3 2025, and 0.91 in Q2 2025.